Category ""
ADVERTISING
Here are five key medical breakthroughs from this year. Bespoke drugs for Alzheimer's patients. ... Doctors are hailing a new treatment for asthma and chronic obstructive pulmonary disease (COPD ...
The US FDA recently approved Cobenfy, a new product introduction in the field of psychiatry. Unlike dopamine-targeting medications, Cobenfy addresses schizophrenia symptoms with fewer side effects. While adverse reactions like nausea and dizziness were reported, further research on its long-term efficacy is needed to discover its full potential.
The year 2025 is poised to bring groundbreaking medical innovations. This includes addressing a wide range of health challenges, from personalized medicine to advanced therapies for chronic diseases.
“This drug takes the first new approach to schizophrenia treatment in decades,” Tiffany Farchione, M.D., director of the Division of Psychiatry, Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, said in a news release.
Gene sequencing at record speeds to identify dangerous mutations. A treatment that delays Type 1 diabetes for years. A vaccine to prevent RSV infections, which kill thousands of Americans each year. Below we describe these and other recent developments in academic medicine that could help save the lives of millions of patients. An RSV vaccine
The Food and Drug Administration approved two genetic treatments for sickle cell disease, including one that uses gene-editing. The approvals offer hope for patients and signal a new medical era.
2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, weight loss, and the first treatment based on the gene-editing technology CRISPR. But 2024 is also ...
From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments for a range of chronic and inherited diseases.
New Treatment Options in Oncology: Advances in Cancer Care Cancer treatment has evolved significantly with the introduction of immunotherapy and CAR-T cell therapy . These treatments harness the body’s immune system to fight cancer, providing a less toxic and more targeted approach than traditional chemotherapy.
The FDA approved a new treatment for sickle cell disease. The therapy is first to use the ground-editing tool CRISPR. ... Dr. Haydar Frangoul, medical director of pediatric hematology-oncology for ...